Georg Süss-Fink Selected Research

phenylacetylene

1/2007

Highly selective hydrogenation of carbon-carbon multiple bonds catalyzed by the cation [(C(6)Me(6))(2)Ru(2)(PPh(2))H(2)](+): molecular structure of [(C(6)Me(6))(2)Ru(2)(PPh(2))(CHCHPh)H](+), a possible intermediate in the case of phenylacetylene hydrogenation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Georg Süss-Fink Research Topics

Disease

10	Neoplasms (Cancer) 10/2019 - 01/2008
2	Ovarian Neoplasms (Ovarian Cancer) 02/2013 - 08/2012
2	Melanoma (Melanoma, Malignant) 01/2009 - 03/2008
1	Toxoplasmosis 01/2017
1	Adenocarcinoma 10/2016
1	Hepatocellular Carcinoma (Hepatoma) 10/2016
1	Photosensitivity Disorders (Photodermatitis) 01/2012
1	Carcinoma (Carcinomatosis) 01/2008
1	Poisoning 01/2007

Drug/Important Bio-Agent (IBA)

9	RutheniumIBA 10/2019 - 01/2007
4	Photosensitizing Agents (Photosensitizers)IBA 01/2012 - 03/2008
4	PorphyrinsIBA 02/2010 - 03/2008
3	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 01/2008
2	SaltsIBA 08/2012 - 01/2007
2	LigandsIBA 02/2010 - 06/2009
2	CationsIBA 01/2008 - 01/2007
1	beta-Galactosidase (Lactaid)IBA 01/2019
1	diruthenium-1IBA 10/2016
1	Estrogens (Estrogen)FDA Link 10/2016
1	Glutathione (Reduced Glutathione)IBA 08/2012
1	ChloridesIBA 08/2012
1	hydroxide ionIBA 08/2012
1	Sulfhydryl Compounds (Thiols)IBA 08/2012
1	4-cymene (p-cymene)IBA 08/2012
1	porphine (porphin)IBA 01/2012
1	5,10,15,20-tetra(4-pyridyl)porphyrinIBA 01/2009
1	Biological ProductsIBA 03/2008
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2008
1	phenylacetyleneIBA 01/2007
1	cyclohexeneIBA 01/2007

Therapy/Procedure

2	Photochemotherapy (Photodynamic Therapy) 01/2012 - 03/2008
2	Lasers (Laser) 01/2009 - 03/2008
1	Therapeutics 01/2009